Rituximab for Pediatric Renal Transplant Rejection
NCT00697996
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Kidney Transplantation
Interventions
DRUG:
Rituximab for transplant rejection
Sponsor
Stanford University
Collaborators
[object Object]